PerkinElmer Inks $200M Loan Agreement

Aug 15, 2017

|

NEW YORK (GenomeWeb) – PerkinElmer disclosed in a filing with the US Securities and Exchange Commission that has signed a $200 million loan agreement with JPMorgan Chase Bank.

The agreement was signed on Aug. 11 and has a term of 364 days. PerkinElmer has the option of getting funds as Eurocurrency Loans or ABR Loans, and the loans are repayable in full at maturity.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

PerkinElmer Inks $200M Loan Agreement

To read the full story....

Breaking News

Biden Administration Funds $1B for COVID-19 Testing in Indian Country

Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test

In Brief This Week: Exact Sciences, Siemens Healthineers, Seegene, Agilent Technologies, and More

Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

What's Popular?

With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit

FDA Grants EUAs for SARS-CoV-2 Tests From Clinical Enterprise, Qorvo Biotechnologies

Sponsorships